eSymposia | Myeloid Cells and Innate Immunity in Solid Tumors
Targeting PI3K-gamma with IPI-549, a Tumor Macrophage-Reprogramming Small Molecule, in Patients with Advanced Solid Tumors
Sep 23, 2020 5:00pm ‐ Sep 23, 2020 5:25pm
Brenda C. O'Connell
, PhD, Infinity Pharmaceuticals, Inc
You must be logged in and own this session in order to post comments.
© 2021 Keystone Symposia & Digitell, Inc. All Rights Reserved